News

Product Announcements and Company News

ICU Medical has acquired Smiths Medical

For our most recent news and events, please click here >>

To learn more about the acquisition, click here >>

Please direct all media inquiries to Tom McCall, ICU Medical, Corporate Vice President, Global Marketing at tom.mccall@icumed.com.

  1. Sharps Safety Products
    Worldwide Notification Regarding the Recall of Jelco® Hypodermic Needle-Pro® Fixed Needle Insulin Syringe with Skewed Graduation Markings
    Smiths Medical has become aware of specific models and lots of Jelco® Hypodermic Needle-Pro® Fixed Needle Insulin Syringes that may exhibit skewed odd number line graduation markings on their syringe barrels.
  2. Infusion Products
    Smiths Medical and Ivenix Partner to Revolutionize Infusion Management with First-Ever Comprehensive Suite of Infusion Solutions in US Healthcare Market
    Smiths Medical, a global medical device leader, today announced it has formed an exclusive partnership with Ivenix, Inc. that positions the companies as the first in the U.S. to offer a comprehensive suite of infusion management solutions to meet healthcare needs across the continuum of care.
  3. Respiratory Products
    Introducing the Portex® Acapella® Choice Blue Vibratory Positive Expiratory Pressure (PEP) Therapy System

    Smiths Medical announces the launch of the acapella® choice blue vibratory PEP therapy system. Acapella® is designed to aid in the removal of secretions for patients who have Cystic Fibrosis, Chronic Obstructive Pulmonary Disease (COPD), asthma, lung disease with secretory problems, and patients with atelectasis.

  4. Infusion Products
    Smiths Medical partners with Parkview Health to enhance patient and clinician safety
    Parkview Health’s integration of the Smiths Medical PharmGuard® Infusion Management System enables smart pump programming and auto documentation to improve safety.
  5. Infusion Products
    ECRI Evaluation of CADD®-Solis V4 Wireless Ambulatory Infusion System
    The report highlights ECRI’s evaluation ratings, test results, and purchasing recommendations for the CADD®-Solis pump.
  6. Pain Management Products
    Launch of Portex® EchoGlo® Peripheral Nerve Block Portfolio
    Smiths Medical, a leading medical device manufacturer, is excited to announce the launch of its EchoGlo® peripheral nerve block portfolio. This addition to the Portex® portfolio of pain management products offers customers a complete solution for regional anesthesia from pump to patient.
  7. Infusion Products
    CADD®-Solis Wireless Communication - Cybersecurity Bulletin

    Smiths Medical is aware of, and currently monitoring, the Cybersecurity and Infrastructure Security Agency (CISA) notification concerning the Cybersecurity Vulnerability, ICSA-20-168-011 (the “Advisory”).

  8. Infusion Products
    Successful Deployment of Bi-Directional Interoperability at University Health System

    Smiths Medical announced today that University Health System (UHS) in San Antonio, Texas has gone live with the PharmGuard® Infusion Management Software System with Bi-Directional Interoperability with Epic.

  9. Infusion Products
    Worldwide Notification Regarding Potential for Inappropriate Bolus or Loading Dose Delivery in Certain Medfusion® 3500 and 4000 Infusion Pumps
    Due to a software error, if a bolus or loading dose is interrupted and a specific sequence of events occurs, over- or under-delivery of a bolus or loading dose may occur.
  10. Sharps Safety Products
    Smiths Medical partners with U.S. government on COVID-19 vaccine efforts

    Smiths Medical partners with US government on COVID-19 vaccine efforts

  11. Infusion Products
    Smiths Medical Cybersecurity Bulletin

    Smiths Medical is aware of, and currently monitoring, the Cybersecurity and Infrastructure Security Agency (CISA) notification concerning the Cybersecurity Vulnerability, ICSA-20-168-01

  12. Infusion Products
    No Smiths Medical products affected by FDA and CISA "URGENT/11" vulnerabilities

    The FDA and CISA announced a set of cybersecurity vulnerabilities referred to as "URGENT/11" that have the potential to introduce risks to certain medical devices or hospital networks.

PreviousNext
12